PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
ConclusionConsidering the radio-cytotoxic effect in the tumour tissue and a delay on tumour doubling time, [125I]PARPi-01 presents a potential radiotherapeutics for treatment of TNBC. Improvements to overcome the suboptimal pharmacokinetics are necessary for its potential clinical application.
Source: EJNMMI Research - Category: Radiology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | CT Scan | Liver | PET Scan | Radiology | SPECT | Study | Thyroid | Thyroid Cancer | Urology & Nephrology